An article covering the world’s first commercialization of a federated learning-based AI drug discovery platform—developed by Elix and LINC using AI models trained on data from 16 pharmaceutical companies—was featured in Nikkei Biotech ONLINE on July 15, 2025, and introduced in AnswersNews on July 8, 2025.

▼ Nikkei Biotech ONLINE (July 15, 2025 – Japanese only, subscription required)
AMEDの創薬AIプロジェクトが事業化、製薬企業16社の創薬関連データを学習
AMED’s Drug Discovery AI Project Commercialized: Learning from Drug Discovery Data of 16 Pharmaceutical Companies
https://bio.nikkeibp.co.jp/atcl/news/p1/25/07/14/13530/

▼ AnswersNews (Updated July 8, 2025 – Japanese only)
ElixとLINC、製薬16社のデータを連合学習したAI創薬プラットフォームを事業化
Elix and LINC Commercialize AI Drug Discovery Platform Developed with Federated Learning Using Data from 16 Pharmaceutical Companies
https://answers.ten-navi.com/pharmanews/30503/